US 7439398
Enantiomerically pure atomoxetine and tomoxetine mandelate
granted A61PA61P25/00A61P43/00
Quick answer
US patent 7439398 (Enantiomerically pure atomoxetine and tomoxetine mandelate) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P25/00, A61P43/00